Holds one active US DMF for orforglipron, filing since 2025. Its 2026 FDA inspection closed as VAI.
Holds one active US DMF for orforglipron, filing since 2025. Its 2026 FDA inspection closed as VAI.
Holds one active US DMF for orforglipron, filing since 2025. Its 2024 FDA inspection closed as VAI.
Holds 5 active US DMFs for orforglipron, filing since 2025.
Holds one active US DMF for orforglipron, filing since 2026.
Holds one active US DMF for orforglipron, filing since 2025.
This page filters the worldwide Orforglipron manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free